hydrazine has been researched along with Cancer, Second Primary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhmedzhanov, F; Brink, AL; Carter, B; Coleman, RL; Fu, S; Gershenson, D; Gong, J; Hong, DS; Jazaeri, A; Leung, CH; Lin, H; McQuinn, L; Meric-Bernstam, F; Naing, A; Pant, S; Piha-Paul, S; Shah, J; Sood, AK; Tsimberidou, A; Westin, SN; Yilmaz, B | 1 |
1 trial(s) available for hydrazine and Cancer, Second Primary
| Article | Year |
|---|---|
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hydrazines; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel | 2023 |